Fré Pharma
ActiveSummary
Fré Pharma has been active since 2012 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €546,583 and a net result of €40,263. Equity is growing by ~25.6% per year across the filed fiscal years. Its solvency ranks better than 42% of 10,584 sector peers (NACE 70, fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Group and network
Holdings and subsidiaries
1 holdingHoldings 1
-
100%
According to the annual accounts to 31-03-2025 of Fré Pharma and those of the other companies, the acts in the Belgian Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Companies Code and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
No directors read yet: 0 of 3 Gazette acts processed.